Your browser doesn't support javascript.
loading
Intrasaccular flow disruption for ruptured aneurysms: an international multicenter study.
Diestro, Jose Danilo Bengzon; Dibas, Mahmoud; Adeeb, Nimer; Regenhardt, Robert W; Vranic, Justin E; Guenego, Adrien; Lay, Sovann V; Renieri, Leonardo; Al Balushi, Ali; Shotar, Eimad; Premat, Kevin; El Naamani, Kareem; Saliou, Guillaume; Möhlenbruch, Markus A; Lylyk, Ivan; Foreman, Paul M; Vachhani, Jay A; Zupancic, Vedran; Hafeez, Muhammad U; Rutledge, Caleb; Rai, Hamid; Tutino, Vincent M; Mirshani, Shervin; Ghozy, Sherief; Harker, Pablo; Alotaibi, Naif M; Rabinov, James D; Ren, Yifan; Schirmer, Clemens M; Goren, Oded; Piano, Mariangela; Kuhn, Anna Luisa; Michelozzi, Caterina; Elens, Stephanie; Starke, Robert M; Hassan, Ameer; Salehani, Arsalaan; Nguyen, Anh; Jones, Jesse; Psychogios, Marios; Spears, Julian; Parra-Fariñas, Carmen; Bres Bullrich, Maria; Mayich, Michael; Salem, Mohamed M; Burkhardt, Jan-Karl; Jankowitz, Brian T; Domingo, Ricardo A; Huynh, Thien; Tawk, Rabih.
Afiliação
  • Diestro JDB; Department of Medical Imaging, Division of Diagnostic and Therapeutic Neuroradiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada danni.diestro@gmail.com.
  • Dibas M; Neuroradiology & Neurointervention Service, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Adeeb N; Department of Neurosurgery and Neurointerventional Surgery, Louisiana State University, Shreveport, Louisiana, USA.
  • Regenhardt RW; Neuroendovascular Program, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Vranic JE; Neuroendovascular Program, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Guenego A; Service de Neuroradiologie Interventionnelle, Hôpital Universitaire Erasme, Bruxelles, Belgique.
  • Lay SV; Service de Neuroradiologie Diagnostique et Thérapeutique, Centre Hospitalier de Toulouse, Hôpital Purpan, Toulouse, France.
  • Renieri L; Interventistica Neurovascolare, Ospedale Careggi di Firenze, Florence, Italy.
  • Al Balushi A; Neurosurgery & Interventional Neuroradiology, New York Presbyterian Hospital, Weill Cornell School of Medicine, New York, New York, USA.
  • Shotar E; Department of Interventional Neuroradiology, Sorbonne University, AP-HP, Pitié Salpêtrière - Charles Foix Hospital, Paris, France.
  • Premat K; Department of Interventional Neuroradiology, Sorbonne University, AP-HP, Pitié Salpêtrière - Charles Foix Hospital, Paris, France.
  • El Naamani K; Department of Neurosurgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Saliou G; Service de radiodiagnostic et radiologie interventionnelle, Centre Hospitalier Vaudois de Lausanne, Lausanne, Switzerland.
  • Möhlenbruch MA; Department of Neuroradiology, Heidelberg University, Heidelberg, Germany.
  • Lylyk I; Equipo de Neurocirugía Endovascular y Radiología Intervencionista, Clínica La Sagrada Familia, Buenos Aires, Argentina.
  • Foreman PM; Neurosurgery Department, Orlando Health Neuroscience and Rehabilitation Institute, Orlando, Florida, USA.
  • Vachhani JA; Neurosurgery Department, Orlando Health Neuroscience and Rehabilitation Institute, Orlando, Florida, USA.
  • Zupancic V; Subdivision of Interventional Neuroradiology, Department of Radiology, Clinical Hospital Center 'Sisters of Mercy', Zagreb, Croatia.
  • Hafeez MU; Department of Neurosurgery, UTMB and Baylor School of Medicine, Houston, Texas, USA.
  • Rutledge C; Department of Neurosurgery, Barrow Neurological Institute, Phoenix, Arizona, USA.
  • Rai H; Department of Neurosurgery, State University of New York at Buffalo, Buffalo, New York, USA.
  • Tutino VM; Department of Neurosurgery, State University of New York at Buffalo, Buffalo, New York, USA.
  • Mirshani S; Neuroradiology & Neurointervention Service, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Ghozy S; Department of Neuroradiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Harker P; Neuroendovascular Program, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Alotaibi NM; Neuroendovascular Program, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Rabinov JD; Neuroendovascular Program, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Ren Y; Interventional Radiology and Neurointerventional Services, Department of Radiology, Austin Health, Melbourne, Melbourne, Victoria, Australia.
  • Schirmer CM; Department of Neurosurgery, Geisinger, Wilkes-Barre, Pennsylvania, USA.
  • Goren O; Department of Neurosurgery, Geisinger, Danville, Pennsylvania, USA.
  • Piano M; Neuroradiology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Kuhn AL; Department of Neurointerventional Radiology, UMass Memorial Hospital, Worcester, Massachusetts, USA.
  • Michelozzi C; Interventistica Neurovascolare, Ospedale San Raffaele, Milano, Italy.
  • Elens S; Service de Neuroradiologie Interventionnelle, Hôpital Universitaire Erasme, Bruxelles, Belgique.
  • Starke RM; Deparment of Neurosurgery, University of Miami, Miami, Florida, USA.
  • Hassan A; Deparment of Neuroscience, Valley Baptist Neuroscience Institute, Harlingen, Texas, USA.
  • Salehani A; Deparments of Neurosurgery and Radiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Nguyen A; Department of Diagnostic and Interventional Neuroradiology, University Hospital Basel, Basel, Switzerland.
  • Jones J; Deparments of Neurosurgery and Radiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Psychogios M; Department of Diagnostic and Interventional Neuroradiology, University Hospital Basel, Basel, Switzerland.
  • Spears J; Department of Medical Imaging, Division of Diagnostic and Therapeutic Neuroradiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Parra-Fariñas C; Department of Surgery, Division of Neurosurgery, University of Toronto, University of Toronto, Toronto, Ontario, Canada.
  • Bres Bullrich M; Department of Medical Imaging, Division of Diagnostic and Therapeutic Neuroradiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Mayich M; Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
  • Salem MM; Departments of Medical Imaging, and Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
  • Burkhardt JK; Department of Neurosurgery, University of Pennsylvania, Penn Medicine, Philadelphia, Pennsylvania, USA.
  • Jankowitz BT; Department of Neurosurgery, University of Pennsylvania, Penn Medicine, Philadelphia, Pennsylvania, USA.
  • Domingo RA; Department of Neurosurgery, University of Pennsylvania, Penn Medicine, Philadelphia, Pennsylvania, USA.
  • Huynh T; Department of Neurologic Surgery, Mayo Clinic, Jacksonville, Florida, USA.
  • Tawk R; Department of Radiology, Mayo Clinic, Jacksonville, Florida.
J Neurointerv Surg ; 15(9): 844-850, 2023 Sep.
Article em En | MEDLINE | ID: mdl-35868856
ABSTRACT

BACKGROUND:

The Woven EndoBridge (WEB) device is a novel intrasaccular flow disruptor tailored for bifurcation aneurysms. We aim to describe the degree of aneurysm occlusion at the latest follow-up, and the rate of complications of aneurysms treated with the WEB device stratified according to rupture status.

METHODS:

Our data were taken from the WorldWideWeb Consortium, an international multicenter cohort including patients treated with the WEB device. Aneurysms were classified into two groups ruptured and unruptured. We compared clinical and radiologic outcomes of both groups. Propensity score matching (PSM) was done to match according to age, gender, bifurcation, location, prior treatment, neck, height, dome width, daughter sac, incorporated branch, pretreatment antiplatelets, and last imaging follow-up.

RESULTS:

The study included 676 patients with 691 intracranial aneurysms (529 unruptured and 162 ruptured) treated with the WEB device. The PSM analysis had 55 pairs. In both the unmatched (85.8% vs 84.3%, p=0.692) and matched (94.4% vs 83.3%, p=0.066) cohorts there was no significant difference in the adequate occlusion rate at the last follow-up. Likewise, there were no significant differences in both ischemic and hemorrhagic complications between the two groups. There was no documented aneurysm rebleeding after WEB device implantation.

CONCLUSION:

There was no significant difference in both the radiologic outcomes and complications between unruptured and ruptured aneurysms. Our findings support the feasibility of treatment of ruptured aneurysms with the WEB device.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aneurisma Intracraniano / Aneurisma Roto / Embolização Terapêutica / Procedimentos Endovasculares Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aneurisma Intracraniano / Aneurisma Roto / Embolização Terapêutica / Procedimentos Endovasculares Idioma: En Ano de publicação: 2023 Tipo de documento: Article